Page last updated: 2024-08-21

dihydroergotamine and Cirrhosis

dihydroergotamine has been researched along with Cirrhosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, L; Cheng, ZY; Dong, M; Jiang, R; Jiang, XX; Jin, WZ; Wang, Q; Xie, W; Yan, CL; Ye, RC; Yuan, SL; Zhang, HL; Zhang, Z; Zheng, KX; Zhou, HQ1
Creutzig, A1
Ghedira, H; Lacronique, J; Malaquin, F; Ostinelli, J; Urban, T1

Other Studies

4 other study(ies) available for dihydroergotamine and Cirrhosis

ArticleYear
Dihydroergotamine ameliorates liver fibrosis by targeting transforming growth factor β type II receptor.
    World journal of gastroenterology, 2023, May-28, Volume: 29, Issue:20

    Topics: Animals; Dihydroergotamine; Fibrosis; Liver Cirrhosis; Mice; Molecular Docking Simulation; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta; Transforming Growth Factor beta1

2023
Fibrosis due to ergot derivatives: exposure to risk should be weighed up.
    Prescrire international, 2002, Volume: 11, Issue:62

    Topics: Dihydroergotamine; Ergotamine; Fibrosis; France; Humans; Methysergide; Risk Assessment; Risk Factors

2002
[Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].
    Deutsche medizinische Wochenschrift (1946), 1992, Nov-06, Volume: 117, Issue:45

    Topics: Coronary Disease; Dihydroergotamine; Ergotamine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Mitral Valve Insufficiency

1992
Pleural and retroperitoneal fibrosis from dihydroergotamine.
    The New England journal of medicine, 1989, Dec-21, Volume: 321, Issue:25

    Topics: Dihydroergotamine; Female; Fibrosis; Humans; Middle Aged; Pleural Diseases; Retroperitoneal Fibrosis

1989